259 related articles for article (PubMed ID: 23349797)
1. DNA methylation in the malignant transformation of meningiomas.
Gao F; Shi L; Russin J; Zeng L; Chang X; He S; Chen TC; Giannotta SL; Weisenberger DJ; Zada G; Mack WJ; Wang K
PLoS One; 2013; 8(1):e54114. PubMed ID: 23349797
[TBL] [Abstract][Full Text] [Related]
2. Integrated genomic analyses of de novo pathways underlying atypical meningiomas.
Harmancı AS; Youngblood MW; Clark VE; Coşkun S; Henegariu O; Duran D; Erson-Omay EZ; Kaulen LD; Lee TI; Abraham BJ; Simon M; Krischek B; Timmer M; Goldbrunner R; Omay SB; Baranoski J; Baran B; Carrión-Grant G; Bai H; Mishra-Gorur K; Schramm J; Moliterno J; Vortmeyer AO; Bilgüvar K; Yasuno K; Young RA; Günel M
Nat Commun; 2017 Feb; 8():14433. PubMed ID: 28195122
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic subclassification of meningiomas based on genome-wide DNA methylation analyses.
Kishida Y; Natsume A; Kondo Y; Takeuchi I; An B; Okamoto Y; Shinjo K; Saito K; Ando H; Ohka F; Sekido Y; Wakabayashi T
Carcinogenesis; 2012 Feb; 33(2):436-41. PubMed ID: 22102699
[TBL] [Abstract][Full Text] [Related]
4. Methylation markers of malignant potential in meningiomas.
Vengoechea J; Sloan AE; Chen Y; Guan X; Ostrom QT; Kerstetter A; Capella D; Cohen ML; Wolinsky Y; Devine K; Selman W; Barnett GH; Warnick RE; McPherson C; Chiocca EA; Elder JB; Barnholtz-Sloan JS
J Neurosurg; 2013 Oct; 119(4):899-906. PubMed ID: 23930849
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic silencing of the kinase tumor suppressor WNK2 is tumor-type and tumor-grade specific.
Jun P; Hong C; Lal A; Wong JM; McDermott MW; Bollen AW; Plass C; Held WA; Smiraglia DJ; Costello JF
Neuro Oncol; 2009 Aug; 11(4):414-22. PubMed ID: 19001526
[TBL] [Abstract][Full Text] [Related]
6. Malignant transformation-related genes in meningiomas: allelic loss on 1p36 and methylation status of p73 and RASSF1A.
Nakane Y; Natsume A; Wakabayashi T; Oi S; Ito M; Inao S; Saito K; Yoshida J
J Neurosurg; 2007 Aug; 107(2):398-404. PubMed ID: 17695396
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation analysis of benign and atypical meningiomas: correlation between RUNX3 methylation and WHO grade.
Majchrzak-Celińska A; Paluszczak J; Szalata M; Barciszewska AM; Nowak S; Baer-Dubowska W
J Cancer Res Clin Oncol; 2015 Sep; 141(9):1593-601. PubMed ID: 25648363
[TBL] [Abstract][Full Text] [Related]
8. DNA methylation of multiple promoter-associated CpG islands in meningiomas: relationship with the allelic status at 1p and 22q.
Bello MJ; Amiñoso C; Lopez-Marin I; Arjona D; Gonzalez-Gomez P; Alonso ME; Lomas J; de Campos JM; Kusak ME; Vaquero J; Isla A; Gutierrez M; Sarasa JL; Rey JA
Acta Neuropathol; 2004 Nov; 108(5):413-21. PubMed ID: 15365725
[TBL] [Abstract][Full Text] [Related]
9. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
[TBL] [Abstract][Full Text] [Related]
10. HOXA7, 9, and 10 are methylation targets associated with aggressive behavior in meningiomas.
Di Vinci A; Brigati C; Casciano I; Banelli B; Borzì L; Forlani A; Ravetti GL; Allemanni G; Melloni I; Zona G; Spaziante R; Merlo DF; Romani M
Transl Res; 2012 Nov; 160(5):355-62. PubMed ID: 22735029
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA methylation of alternative promoter of DLC1 isoform 1 in meningiomas.
Bujko M; Kober P; Rusetska N; Wakuła M; Goryca K; Grecka E; Matyja E; Neska J; Mandat T; Bonicki W; Siedlecki JA
J Neurooncol; 2016 Dec; 130(3):473-484. PubMed ID: 27614886
[TBL] [Abstract][Full Text] [Related]
12. Aberrant CpG island hypermethylation profile is associated with atypical and anaplastic meningiomas.
Liu Y; Pang JC; Dong S; Mao B; Poon WS; Ng HK
Hum Pathol; 2005 Apr; 36(4):416-25. PubMed ID: 15892004
[TBL] [Abstract][Full Text] [Related]
13. Microarray gene expression profiling in meningiomas: differential expression according to grade or histopathological subtype.
Fèvre-Montange M; Champier J; Durand A; Wierinckx A; Honnorat J; Guyotat J; Jouvet A
Int J Oncol; 2009 Dec; 35(6):1395-407. PubMed ID: 19885562
[TBL] [Abstract][Full Text] [Related]
14. Microarray-based gene expression profiling of benign, atypical and anaplastic meningiomas identifies novel genes associated with meningioma progression.
Wrobel G; Roerig P; Kokocinski F; Neben K; Hahn M; Reifenberger G; Lichter P
Int J Cancer; 2005 Mar; 114(2):249-56. PubMed ID: 15540215
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide DNA methylation analysis reveals molecular subtypes of pancreatic cancer.
Mishra NK; Guda C
Oncotarget; 2017 Apr; 8(17):28990-29012. PubMed ID: 28423671
[TBL] [Abstract][Full Text] [Related]
16. [MOLECULAR PATHOLOGY OF MENINGIOMAS].
Murnyák B; Csonka T; Hortobágyi T
Ideggyogy Sz; 2015 Sep; 68(9-10):292-300. PubMed ID: 26665490
[TBL] [Abstract][Full Text] [Related]
17. Masked hypodiploidy in anaplastic meningiomas by duplication of the original clone found in atypical meningiomas: illustration of the evolution of genetic alterations.
Ely EE; Guzman MA; Calvey LS; Batanian JR
Neuropathology; 2014 Aug; 34(4):353-9. PubMed ID: 24612240
[TBL] [Abstract][Full Text] [Related]
18. Pathodiagnostic parameters and evaluation of O⁶- methyl guanine methyl transferase gene promoter methylation in meningiomas.
Jabini R; Moradi A; Afsharnezhad S; Ayatollahi H; Behravan J; Raziee HR; Mosaffa F
Gene; 2014 Apr; 538(2):348-53. PubMed ID: 24398011
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive genetic and epigenetic analysis of sporadic meningioma for macro-mutations on 22q and micro-mutations within the NF2 locus.
Hansson CM; Buckley PG; Grigelioniene G; Piotrowski A; Hellström AR; Mantripragada K; Jarbo C; Mathiesen T; Dumanski JP
BMC Genomics; 2007 Jan; 8():16. PubMed ID: 17222329
[TBL] [Abstract][Full Text] [Related]
20. Differential expression profiling analyses identifies downregulation of 1p, 6q, and 14q genes and overexpression of 6p histone cluster 1 genes as markers of recurrence in meningiomas.
Pérez-Magán E; Rodríguez de Lope A; Ribalta T; Ruano Y; Campos-Martín Y; Pérez-Bautista G; García JF; García-Claver A; Fiaño C; Hernández-Moneo JL; Mollejo M; Meléndez B
Neuro Oncol; 2010 Dec; 12(12):1278-90. PubMed ID: 20685720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
